Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (66)
  • 2024 (90)
  • 2023 (75)
  • 2022 (71)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4015)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Fentanyl Awareness (152)

Drug Name

  • Fentanyl (105)
  • Opioids (50)
  • Oxycodone (47)
  • Synthetic Opioids (17)
  • Methamphetamine (16)
  • Hydromorphone (12)
  • Cocaine (9)
  • Benzodiazepines (7)
  • Heroin (7)
  • Morphine (7)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)

Field Division

  • Washington, DC (43)
  • St. Louis (39)
  • Houston (33)
  • New York (27)
  • Miami (22)
  • Omaha (22)
  • Chicago (20)
  • Atlanta (18)
  • Sede (18)
  • Louisville (17)
  • Rocky Mountain (15)
  • Los Angeles (14)
  • New Jersey (14)
  • El Paso (13)
  • Seattle (13)
  • New Orleans (10)
  • Dallas (8)
  • San Francisco (8)
  • New England (7)
  • Phoenix (7)
  • San Diego (6)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Wisconsin Naturopathic Practitioner Sentenced to Twelve Months’ Imprisonment for Unlawful Prescribing of Controlled Substances

Mayo 15, 2023
MILWAUKEE - John J. McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee, and U.S. Attorney Gregory J. Haanstad for the Eastern District of Wisconsin, announced that on May 12, 2023, Michele Nickels. was sentenced to12 months and one day of imprisonment, to be followed by two years...
Mayo 15, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

Mayo 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
Mayo 09, 2023
PRESS RELEASE

Rocky Mountain Field Division Removes Almost 900,000 Potentially Deadly Doses of Fentanyl from its Communities During Operation Last Mile

Mayo 09, 2023
DENVER– Last week, the U.S. Drug Enforcement Administration announced the results of a year-long national initiative, “Operation Last Mile,” which targeted operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels. Specifically, the operation targeted those in our communities responsible for the last mile of fentanyl and methamphetamine distribution...
Mayo 09, 2023
PRESS RELEASE

DEA Recognizes National Fentanyl Awareness Day

Mayo 08, 2023
WASHINGTON – DEA is proud to join “Song for Charlie” and many of our valued law enforcement, public health, and non-profit partners in recognizing National Fentanyl Awareness Day. Tomorrow represents an important opportunity to remember the victims of fentanyl poisoning and educate people in our communities about the deadly threat...
Mayo 08, 2023
PRESS RELEASE

DEA Operation Last Mile Tracks Down Sinaloa and Jalisco Cartel Associates Operating within the United States

Mayo 08, 2023
NEW ORLEANS – Today, the U.S. Drug Enforcement Administration announced the results of a year-long national operation, “Operation Last Mile,” targeting operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels responsible for the last mile of fentanyl and methamphetamine distribution on our streets and on social media. DEA’s...
Mayo 08, 2023
PRESS RELEASE

DEA Operation Last Mile Tracks Down Sinaloa and Jalisco Cartel Associates Operating within the United States

Mayo 08, 2023
NEWARK, N.J. – Today, the U.S. Drug Enforcement Administration announced the results of a year-long national operation, “Operation Last Mile,” targeting operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels responsible for the last mile of fentanyl and methamphetamine distribution on our streets and on social media. DEA’s...
Mayo 08, 2023
PRESS RELEASE

DEA to host summit on Medication for Opioid Use Disorder (MOUD) in Charleston, WV

Abril 04, 2023
Louisville, Ky. – The Drug Enforcement Administration (DEA) and the State of West Virginia are hosting a discussion on Medication for Opioid Use Disorder (MOUD) in Charleston, West Virginia on Saturday, April 15, 2023 from 12:00 p.m. to 5:00 p.m. The event will take place at the University of Charleston’s...
Abril 04, 2023
PRESS RELEASE

Law Enforcement Partners Host Second Annual Nebraska Drug Forum

Marzo 29, 2023
KEARNEY, Neb. – As drug trends change and overdose incidents increase across the country, law enforcement partners continue working to counter the threat to Nebraska communities through enforcement and education. That ongoing partnership was on display for law enforcement agencies and county attorneys during this week’s second annual Nebraska Drug...
Marzo 29, 2023
PRESS RELEASE

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations

Marzo 24, 2023
INDIANAPOLIS - A joint investigation by Drug Enforcement Administration-Indianapolis and the Indianapolis Metropolitan Police Department (IMPD) has led to the arrest of Zennon Gaines, a pharmacy technician from Indianapolis, who has been charged with multiple violations, including felony dealing and possession of a controlled substance by fraud/forgery. The joint investigation...
Marzo 24, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
Showing 201 - 210 of 376 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Current page 21
  • Página 22
  • Página 23
  • Página 24
  • Página 25
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster